Skip to Main Content

Paper Details

The propriety of upgrading responses to venetoclaxâ¿¿+â¿¿azacitidine in newly diagnosed patients with acute myeloid leukemia.
Leuk Lymphoma
7
2021
AML, IC, acute myeloid leukemia, azacitidine, blood, cytopenias, patients, venetoclax
Author NameAffiliation
Diana AbbottUniversity of Colorado
Maria AmayaUniversity of Colorado School of Medicine
Amanda WintersUniversity of Colorado School of Medicine
Veronica Clavijo JordanUniversity of Colorado School of Medicine
Veronica Clavijo JordanUniversity of Colorado School of Medicine
Clayton A SmithUniversity of Colorado School of Medicine
Daniel A PollyeaUniversity of Colorado School of Medicine
  • 1 - 7

Datasets